INCY - Incyte Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Total Revenue
2,107,772
2,158,759
1,881,883
1,536,216
1,105,719
Cost of Revenue
108,377
114,200
94,100
79,500
58,200
Gross Profit
1,999,395
2,044,559
1,787,783
1,456,716
1,047,519
Operating Expenses
Research Development
1,145,482
1,154,111
1,197,957
1,326,361
581,861
Selling General and Administrative
440,892
468,711
434,407
366,406
303,251
Total Operating Expenses
1,586,374
1,622,822
1,632,364
1,692,767
885,112
Operating Income or Loss
413,021
421,737
155,419
-236,051
162,407
Interest Expense
1,603
1,855
1,543
6,900
38,745
Total Other Income/Expenses Net
20,109
66,958
-38,506
-86,860
-20,683
Income Before Tax
431,504
486,791
115,347
-312,290
107,404
Income Tax Expense
26,540
39,885
5,854
852
3,182
Income from Continuing Operations
404,964
446,906
109,493
-313,142
104,222
Net Income
404,964
446,906
109,493
-313,142
104,222
Net Income available to common shareholders
404,964
446,906
109,493
-313,142
104,222
Reported EPS
Basic
-
2.08
0.52
-1.53
0.55
Diluted
-
2.05
0.51
-1.53
0.54
Weighted average shares outstanding
Basic
-
214,913
212,383
204,580
187,873
Diluted
-
217,657
215,635
204,580
194,125
EBITDA
-
543,179
171,859
-253,212
204,574